
Spruce Biosciences SPRB
€ 34.61
-6.84%
Spruce Biosciences EV/EBITDA | SPRB
EV/EBITDA Jährlich Spruce Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.252 | 0.396 | 0.763 | -0.981 | -1.82 | -15.8 | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 0.763 | -15.8 | -2.95 |
EV/EBITDA anderer Aktien in der Pharmaeinzelhändler
| Name | EV/EBITDA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Avid Bioservices
CDMO
|
-87.3 | - | - | $ 789 M | ||
|
Zosano Pharma Corporation
ZSAN
|
-1.92 | - | 7.23 % | $ 2.72 M | ||
|
Spectrum Pharmaceuticals
SPPI
|
-2.18 | - | - | $ 189 M | ||
|
Alpine Immune Sciences
ALPN
|
-0.183 | - | - | $ 2.17 B | ||
|
Berkeley Lights
BLI
|
-1.29 | - | -7.31 % | $ 87 M | ||
|
Kaleido Biosciences
KLDO
|
-0.876 | - | -3.69 % | $ 12.4 M | ||
|
VBI Vaccines
VBIV
|
0.18 | - | -50.87 % | $ 1.09 M | ||
|
CTI BioPharma Corp.
CTIC
|
-8.52 | - | - | $ 1.2 B | ||
|
Decibel Therapeutics
DBTX
|
-1.75 | - | - | $ 123 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-316 | $ 26.35 | -3.02 % | $ 3.35 B | ||
|
IVERIC bio
ISEE
|
-13.8 | - | - | $ 5.51 B | ||
|
ObsEva SA
OBSV
|
-1.92 | - | -15.52 % | $ 10.5 M | ||
|
Arrowhead Pharmaceuticals
ARWR
|
-9.74 | $ 41.53 | -4.86 % | $ 5.88 B | ||
|
Monopar Therapeutics
MNPR
|
-20.5 | $ 69.02 | -1.81 % | $ 512 M | ||
|
Poseida Therapeutics
PSTX
|
-3.48 | - | - | $ 857 M | ||
|
Y-mAbs Therapeutics
YMAB
|
-5.77 | - | - | $ 382 M | ||
|
Satsuma Pharmaceuticals
STSA
|
-0.268 | - | -0.9 % | $ 36.5 M | ||
|
Anavex Life Sciences Corp.
AVXL
|
-3.84 | $ 0.59 | -11.3 % | $ 50.3 M | ||
|
SpringWorks Therapeutics
SWTX
|
-16.3 | - | - | $ 3.48 B | ||
|
Axon Enterprise
AXON
|
1.57 K | $ 291.02 | -5.2 % | $ 22.7 B | ||
|
Infinity Pharmaceuticals
INFI
|
-0.898 | - | -46.98 % | $ 3.57 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.142 | - | - | $ 7.46 M | ||
|
Evelo Biosciences
EVLO
|
-0.456 | - | -14.46 % | $ 27.9 M | ||
|
Morphic Holding
MORF
|
-8.35 | - | - | $ 2.42 B | ||
|
Genocea Biosciences
GNCA
|
-1.28 | - | -15.0 % | $ 3.04 M | ||
|
Biogen
BIIB
|
48.2 | $ 249.55 | 0.98 % | $ 36.6 B | ||
|
Bristol-Myers Squibb Company
BMY
|
45.8 | $ 58.74 | 0.69 % | $ 119 B | ||
|
Eiger BioPharmaceuticals
EIGR
|
-0.433 | - | -9.21 % | $ 2.55 M | ||
|
IGM Biosciences
IGMS
|
-1.38 | - | - | $ 76.9 M | ||
|
Merrimack Pharmaceuticals
MACK
|
-101 | - | - | $ 216 M | ||
|
Rubius Therapeutics
RUBY
|
-0.028 | - | -33.55 % | $ 7.81 M | ||
|
Mirati Therapeutics
MRTX
|
-3.35 | - | - | $ 3.3 B | ||
|
InVivo Therapeutics Holdings Corp.
NVIV
|
0.956 | - | -37.48 % | $ 476 K | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.361 | - | -9.72 % | $ 5.89 M | ||
|
Orchard Therapeutics plc
ORTX
|
-5.82 | - | 1.02 % | $ 90.8 M | ||
|
La Jolla Pharmaceutical Company
LJPC
|
11.3 | - | - | $ 154 M | ||
|
Oyster Point Pharma
OYST
|
-2.51 | - | - | $ 300 M | ||
|
Intercept Pharmaceuticals
ICPT
|
-60.9 | - | - | $ 643 M | ||
|
Chinook Therapeutics
KDNY
|
-7.76 | - | - | $ 2.6 B | ||
|
Syros Pharmaceuticals
SYRS
|
-0.204 | - | -8.44 % | $ 3.4 M | ||
|
NanoViricides
NNVC
|
-3.68 | $ 1.15 | -2.54 % | $ 23.2 M | ||
|
GT Biopharma
GTBP
|
0.233 | $ 2.93 | -7.86 % | $ 16.2 M | ||
|
Zymeworks
ZYME
|
-3.7 | $ 26.41 | -1.68 % | $ 1.36 B | ||
|
Aldeyra Therapeutics
ALDX
|
-8.12 | $ 0.84 | 16.41 % | $ 50.4 M | ||
|
Citius Pharmaceuticals
CTXR
|
-1.5 | $ 0.51 | 1.61 % | $ 5.64 M | ||
|
Cytokinetics, Incorporated
CYTK
|
-3.27 | $ 50.7 | -1.48 % | $ 6.09 M | ||
|
DBV Technologies S.A.
DBVT
|
-18.7 | $ 9.03 | -4.14 % | $ 1.26 B | ||
|
Precision BioSciences
DTIL
|
-0.315 | $ 7.37 | 6.66 % | $ 94.5 M | ||
|
Exelixis
EXEL
|
13.2 | $ 64.59 | -1.88 % | $ 17.5 B | ||
|
Fennec Pharmaceuticals
FENC
|
-26.6 | $ 13.09 | -2.68 % | $ 374 M |